C07C 219/14
Having at least one of the hydroxy groups esterified by a carboxylic
Official title: having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
C07C219/14 (Having at least one of the hydroxy groups esterified by a carboxylic) appears on 49 US grants and 49 published applications in this corpus.
Search patents in C07C- Granted patents
- 49
- Published applications
- 49
- Assignees
- 40
- Inventors
- 144
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 4 |
| 2004 | 0 | 1 |
| 2005 | 2 | 1 |
| 2006 | 1 | 2 |
| 2007 | 1 | 5 |
| 2008 | 1 | 2 |
| 2009 | 2 | 2 |
| 2010 | 4 | 4 |
| 2011 | 1 | 3 |
| 2012 | 1 | 0 |
| 2013 | 4 | 1 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 2 | 2 |
| 2021 | 4 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 3 |
| 2024 | 1 | 4 |
| 2025 | 2 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound [2-(dimethylamino)-2-phenylbutyl]-3,4,5-trimethoxybenzoate 4-methyl-2H-chromen-2-on-7-yl sulphate and use thereof16 Dec 2025US 12,497,376 B2Ltd “Valenta-Intellekt”
- Benzoate derivatives28 Oct 2025US 12,454,506 B2Zhejiang Yuejia Pharmaceuticals Co., Ltd
- Benzoate derivatives20 Aug 2024US 12,065,397 B2Zhejiang Yuejia Pharmaceuticals Co., Ltd
- High penetration drugs and their compositions thereof for treatment of Parkinson diseases27 Jun 2023US 11,685,739 B2Techfields Pharma Co., Ltd.
- Resist composition and patterning process9 Aug 2022US 11,409,194 B2Shin-Etsu Chemical Co., Ltd.
- Tricine and citric acid-based cationic lipids with aromatic head groups6 Aug 2026US 2026/0224489 A1Sanofi
- Compounds, compositions, and methods for reducing production of trimethylamine1 Jan 2026US 2026/0001833 A1The Cleveland Clinic Foundation
- Composition, substrate treatment method, manufacturing method of semiconductor device, and compound3 Jul 2025US 2025/0215126 A1FUJIFILM Corporation
- Broad-spectrum antiviral drugs20 Feb 2025US 2025/0057802 A1
- Benzoate derivatives31 Oct 2024US 2024/0360073 A1Zhejiang Yuejia Pharmaceuticals Co., Ltd
Most cited
By later US patents
- Catechol diethers as selective PDE.sup.IV inhibitors71US 5,814,651 APfizer Inc. · 1998
- Methods for increasing uridine levels with L-nucleosides35US 5,567,689 AThe UAB Research Foundation · 1996
- Cat-1 inhibitors, pharmaceutical compositions and methods of use20US 5,344,843 AHoffman-La Roche Inc. · 1994
- Ester derivatives19US 6,846,835 B2Banyu Pharmaceutical Co., Ltd. · 2005
- Methods and compositions for inhibiting uridine secretion18US 5,723,449 AThe UAB Research Foundation · 1998